SEC Form 4 · accession 0001623919-16-000073
EndoChoice Holdings, Inc. · GI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David L Kaufman
Director
Period of report
Apr 29, 2016
Accepted (ET)
May 3, 2016 · 5:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001623919
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.001 per shareF2,F3 | Apr 29, 2016 | A | 5,462 | $0.00 | A | 11,087 | D | |
| Common stock, par value $0.001 per shareF1 | holding | — | — | — | 2,088,209 | I | By Envest III, LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person is a Founder and Senior Managing Director of Envest Holdings LLC and as a result may be deemed to beneficially own the shares owned by Envest Holdings or related entities.
- F2These shares represent an award of restricted stock units that will be settled in common stock upon vesting. The restricted stock units will vest on April 29, 2017, which is one year from the grant date.
- F3The total direct shares shown includes 11,087 time-vesting restricted stock and/or unit award shares.